NBI-921355

N/A

Report date: 2025/04/15 16:03:31
NME

Base Information

Drug NameNBI-921355
Drug Alias NameNBI-921355NBI'355
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type II alpha subunit inhibitorsSodium channel protein type VIII alpha subunit inhibitors
TargetsSodium channel protein type II alpha subunitSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences Inc
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A